Found 25 matching trials
A Study of Enzalutamide Plus the Glucocorticoid Receptor Antagonist Relacorilant Versus Placebo for Patients With High-risk Localized Prostate Cancer PHASE2 Researchers conducting this study hope to learn about the safety and effect...
Show More Location
University of Chicago Comprehensive Cancer Center
Learn More & Join Trial
Extension Study to Evaluate the Safety of Long-Term Use of Relacorilant in Patients With Cushing Syndrome PHASE2 This is an open-label extension study to evaluate the long-term safety of r...
Show More Status
Active Not Recruiting
Learn More & Join Trial
T/QT Study to Investigate the Effect of Relacorilant on Cardiac Repolarization in Healthy Volunteers PHASE1 This dedicated T/QT study will investigate the effect of relacorilant on ca...
Show More Learn More & Join Trial
Relacorilant in Combination With Nab-Paclitaxel in Advanced, Platinum-Resistant, High-Grade Epithelial Ovarian, Primary Peritoneal, or Fallopian-Tube Cancer PHASE3 The primary objectives of this study are to evaluate progression-free survi...
Show More Status
Active Not Recruiting
Learn More & Join Trial
Relacorilant With Nab-Paclitaxel and Gemcitabine in Patients With Metastatic Pancreatic Adenocarcinoma PHASE2 This is a 2-part, Phase 2 study to evaluate the safety, tolerability, dosin...
Show More Learn More & Join Trial
Study in Healthy Subjects to Determine the Effect of Relacorilant on Exposure to Probe Substrates for Cytochrome P450s PHASE1 This is an open-label, single-sequence, 3-period crossover study conducted ...
Show More Learn More & Join Trial
A Study to Evaluate the Pharmacokinetics of the CORT125134 Phase 2 Formulation in Healthy Male Subjects PHASE1 A study designed to characterize the pharmacokinetic (PK) profile of CORT12...
Show More Learn More & Join Trial
A Study to Evaluate the Pharmacokinetics of the Current Capsule Formulation of CORT125134 in Healthy Subjects PHASE1 A study designed to characterize the plasma pharmacokinetic (PK) profile of...
Show More Location
Quotient Sciences, Miami, Inc.
Learn More & Join Trial
A Study to Evaluate the Effects of Hepatic Impairment on the Pharmacokinetics of Relacorilant PHASE1 The primary objective of this multiple-dose, adaptive design study is to ev...
Show More Location
Clinical Pharmacology of Miami, LLC
Learn More & Join Trial
Study to Evaluate CORT125134 in Participants With Cushing's Syndrome PHASE2 Cushing's syndrome is a relatively rare disorder caused by prolonged exposu...
Show More Location
Multiple Locations
Learn More & Join Trial